Gleason Grade Group 4 prostate biopsy with no cancer seen on final pathology in the magnetic resonance imaging and Prostate Specific Membrane Antigen‐Positron Emission Tomography era

Gleason Grade Group 4 prostate biopsy with no cancer seen on final pathology in the magnetic resonance imaging and Prostate Specific Membrane Antigen‐Positron Emission Tomography era

Introduction: The absence of prostate cancer on final surgical pathology after biopsy‐proven prostate cancer is a rare finding. Case presentation: Case of pT0 prostate cancer following Gleason Grade Group 4 in 1 out of 12 cores from a transrectal ultrasound‐guided biopsy in a man who underwent both...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:IJU Case Reports 2023-11, Vol.6 (6), p.337-340
Hauptverfasser: Mookerji, Nikhile, Mittal, Rohan, Hui, Amaris, Pfanner, Tyler, Broomfield, Stacey, Dean, Luke, Adam, Benjamin, Fung, Christopher, Tamm, Alexander, Kinnaird, Adam
Format: Artikel
Sprache:eng
Schlagworte:
Antigens
Biopsy
Cancer therapies
Case Report
Case Reports
Clinical trials
Conflicts of interest
Health aspects
Magnetic resonance imaging
multiparametric MRI
Pathology
Patients
PET imaging
Prostate cancer
PSMA PET
Robotics
Stains & staining
Surgery
Tomography
vanishing cancer
Writing
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Introduction: The absence of prostate cancer on final surgical pathology after biopsy‐proven prostate cancer is a rare finding. Case presentation: Case of pT0 prostate cancer following Gleason Grade Group 4 in 1 out of 12 cores from a transrectal ultrasound‐guided biopsy in a man who underwent both magnetic resonance imaging and [sup.18]F‐PSMA‐1007 Positron Emission Tomography prior to radical prostatectomy. Conclusion: pT0 prostate cancer is rare. The use of novel imaging modalities may help in the workup of prostate cancer.
ISSN:2577-171X
2577-171X
DOI:10.1002/iju5.12614